ACG Clinical Guideline: Treatment of Helicobacter pylori Infection

Select Content Type
Resources
Authored By
Shalina MedSpace
Authored On
Interests
Cardiology
Dermatology
Emergency Medicine
Endocrinology
ENT
Gastroenterology
Hematology
Immunology Allergy & Inflammation
Infectious Disease & Vaccines
Internal/Family Medicine
Neurology
Obstetrics & Gynecology
Oncology
Ophthalmology
Orthopedic
Pain & Anesthesiology
Pediatric Medicine
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology & Nephrology
Speciality
Cardiology
Dentistry
Dermatology
Emergency Medicine
Endocrinology
ENT
Gastroenterology
Geriatrics
Hematology
Immunology Allergy & Inflammation
Infectious Disease & Vaccines
Internal/Family Medicine
Medical Genetics
Neurology
Obstetrics & Gynecology
Oncology
Ophthalmology
Orthopedic
Pain & Anesthesiology
Pathology
Pediatric Medicine
Pharmacology
Psychiatry
Public Health
Pulmonology
Radiology
Rheumatology
Surgery
Urology & Nephrology
Thumbnail Image
ACG_thumbnail
Detail Image
ACG_mobile
Book Detail
Actions
Download in App
Countries of release
India
Nigeria
UAE
IS_Ebsco
false
Description

Helicobacter pylori infection is a widespread cause of peptic ulcer disease and gastric cancer, with links to dyspepsia, aspirin- and NSAID-related ulcer risk, unexplained iron deficiency anemia, and idiopathic thrombocytopenic purpura. 


The ACG guidelines emphasize tailoring treatment based on prior antibiotic exposure and local resistance patterns. These are updated recommendations on drug selection, dosing, and treatment duration.

Published Date